HEPATITIS C VIRUS (HCV) INFECTION AND RE-INFECTION IN ILLICIT DRUG USERS

被引：0
|
作者：
Barrieshee, Ahmed [1 ]
Tossonian, Harout [1 ]
Grebely, Jason [4 ]
Raffa, Jesse D. [3 ]
Gallagher, Lesley [1 ]
Storms, Michelle M. [1 ]
Duncan, Fiona [2 ]
DeVlaming, Stanley [2 ]
Conway, Brian [1 ,2 ]
机构：
[1] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[2] Vancouver Coastal Hlth, Pender Community Hlth Ctr, Vancouver, BC, Canada
[3] Univ Waterloo, Dept Stat & Actuarial Sci, Waterloo, ON N2L 3G1, Canada
[4] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia
来源：
HEPATOLOGY | 2009年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
773
引用
收藏
页码：666A / 666A
页数：1
相关论文
共 50 条
  • [21] Optimizing assessment and treatment for hepatitis C virus (HCV) infection in illicit drug users: a model incorporating multidisciplinary care and peer-support
    Duncan, F.
    Grebely, J.
    Knight, E.
    Ngai, T.
    Genoway, K.
    Viljoen, M.
    Storms, M.
    Gallagher, L.
    Elliott, D.
    Raffa, J. D.
    Conway, B.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A352 - A353
  • [22] Hepatitis C virus infection among Alaskan drug users
    Fisher, DG
    Fenaughty, AM
    Paschane, AA
    Paschane, DM
    Cagle, HH
    Orr, SM
    AMERICAN JOURNAL OF PUBLIC HEALTH, 1997, 87 (10) : 1722 - 1724
  • [23] Treatment of hepatitis C virus infection in intravenous drug users
    Cowan, Matthew L.
    Maxwell, James D.
    ACTA NEUROPSYCHIATRICA, 2006, 18 (05): : 183 - 192
  • [24] Hepatitis B and C Re-infection: Prophylaxis and Therapy
    Bahra, M.
    Seehofer, D.
    Neumann, U. P.
    Berg, T.
    GASTROENTEROLOGE, 2009, 4 (06): : 526 - 539
  • [25] Hepatitis C Virus (HCV)-Specific T Cell Responses in Injection Drug Users with Apparent Resistance to HCV Infection
    Thurairajah, Prem H.
    Hegazy, Doha
    Chokshi, Shilpa
    Shaw, Steve
    Demaine, Andrew
    Kaminski, Edward R.
    Naoumov, Nikolai V.
    Cramp, Matthew E.
    JOURNAL OF INFECTIOUS DISEASES, 2008, 198 (12): : 1749 - 1755
  • [26] Hepatitis C virus (HCV) core antigen assay to detect ongoing HCV infection in Thai injection drug users
    Netski, DM
    Wang, XH
    Mehta, SH
    Nelson, K
    Celentano, D
    Thongsawat, S
    Maneekarn, N
    Suriyanon, V
    Jittiwutikorn, J
    Thomas, DL
    Ticehurst, JR
    JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (04) : 1631 - 1636
  • [27] Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users
    Grebely, Jason
    Matthews, Gail V.
    Hellard, Margaret
    Shaw, David
    van Beek, Ingrid
    Petoumenos, Kathy
    Alavi, Maryam
    Yeung, Barbara
    Haber, Paul S.
    Lloyd, Andrew R.
    Kaldor, John M.
    Dore, Gregory J.
    JOURNAL OF HEPATOLOGY, 2011, 55 (01) : 76 - 85
  • [28] Co-infection with hepatitis C virus (HCV) in Estonian intravenous drug users HIV epidemic
    Kristi Huik
    Heli Rajasaar
    Radko Avi
    Merit Pauskar
    Valentina Ustina
    Kersti Kink
    Lilia Novikova
    Matti Maimets
    Kai Zilmer
    Irja Lutsar
    BMC Infectious Diseases, 14 (Suppl 4)
  • [29] Acute hepatitis C virus re-infection in a heterosexual HIV-positive partner
    Soriano, Vincent
    Labarga, Pablo
    de Mendoza, Carmen
    Barreiro, Pablo
    LIVER INTERNATIONAL, 2016, 36 (05) : 763 - 763
  • [30] Benefits of hepatitis C virus treatment: A balance of preventing onward transmission and re-infection
    de Vos, A. S.
    Kretzschmar, M. E. E.
    MATHEMATICAL BIOSCIENCES, 2014, 258 : 11 - 18
12345